Related Experiment Video
Updated: May 29, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Hypertension and CKD
Rene G VanDeVoorde1, Mark M Mitsnefes
1Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, OH 45229-3039, USA.
Insights
Hypertension affects over half of pediatric patients with chronic kidney disease (CKD), with aggressive blood pressure control crucial for preventing cardiovascular issues and slowing CKD progression.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Health in Children
- Chronic Kidney Disease (CKD) Management
Background:
- Hypertension is prevalent in over 50% of pediatric patients with chronic kidney disease (CKD).
- Prevalence varies by CKD etiology, with acquired renal disorders showing higher rates similar to adults.
- Masked hypertension is also common in children with CKD, as indicated by ambulatory blood pressure monitoring.
Purpose of the Study:
- To highlight the significant prevalence of hypertension in pediatric CKD.
- To emphasize the link between uncontrolled hypertension and CKD progression and end-organ damage.
- To underscore the importance of aggressive hypertension management in pediatric CKD care.
Main Methods:
- Review of existing literature and clinical findings on hypertension in pediatric CKD.
- Analysis of ambulatory blood pressure monitoring data.
- Consideration of outcomes from major clinical trials like the ESCAPE trial.
Main Results:
- Hypertension is a common comorbidity in pediatric CKD, particularly with acquired renal disorders.
- Uncontrolled hypertension accelerates CKD progression and leads to end-organ damage (cardiomyopathy, atherosclerosis).
- Aggressive blood pressure control, targeting below the 50th percentile, shows significant benefits in pediatric CKD patients.
Conclusions:
- Aggressive treatment of hypertension is essential for managing pediatric CKD.
- Effective blood pressure management can prevent cardiovascular complications and delay CKD progression.
- Targeting blood pressure below the 50th percentile offers greater benefits in pediatric CKD than observed in adult studies.
Abstract:
Hypertension is found in more than 50% of pediatric patients with CKD. However, its prevalence varies according to the cause of CKD. It is relatively infrequent in children with structural disorders. Acquired renal disorders are associated with an increased prevalence of hypertension, similar to that of adults. Recent studies using ambulatory blood pressure monitoring indicate that children with CKD also have a high prevalence of masked hypertension. Similar to adults, long-standing and uncontrolled hypertension in children is associated with the progression of CKD and development of end-organ damage including early cardiomyopathy and premature atherosclerosis. Aggressive treatment of hypertension should be an essential part of pediatric CKD care, not just to prevent the development of symptomatic cardiovascular disease but also to delay progression of CKD. Recent findings from the European Effect of Strict Blood Pressure Control and ACE Inhibition on Progression of Chronic Renal Failure in Pediatric Patients (ESCAPE) trial have shown that the aggressive treatment of blood pressure, to below the 50th percentile, has even greater benefit in children with CKD, unlike results seen in adult studies.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease II: Clinical Manifestations
Hypertension I: Introduction
Hypertension II: Pathophysiology
